These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8468921)

  • 1. Cytokines and mesangial cells.
    Sterzel RB; Schulze-Lohoff E; Marx M
    Kidney Int Suppl; 1993 Jan; 39():S26-31. PubMed ID: 8468921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion.
    Ruef C; Kashgarian M; Coleman DL
    Am J Pathol; 1992 Aug; 141(2):429-39. PubMed ID: 1323220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-mesangial cell interaction modulates migration of macrophages.
    Singhal PC; Franki N; Gibbons N; Reddy K
    J Investig Med; 1998 Dec; 46(9):453-9. PubMed ID: 9861781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and extracellular matrix-cell interactions in kidney disease.
    Makino H; Sugiyama H; Kashihara N
    Kidney Int Suppl; 2000 Sep; 77():S67-75. PubMed ID: 10997693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of mesangial cells and the extracellular matrix in the glomerulus].
    Sterzel RB
    Verh Dtsch Ges Pathol; 1989; 73():36-8. PubMed ID: 2482621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.
    Floege J; Eng E; Young BA; Johnson RJ
    Kidney Int Suppl; 1993 Jan; 39():S47-54. PubMed ID: 8468926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesangial cell-matrix interactions: modulation of matrix expression in mesangial cells by extracellular matrices.
    Sakatsume M; Saito A; Takeda T; Yamazaki H; Narita I; Nishi S; Nakagawa Y; Arakawa M
    Exp Nephrol; 1995; 3(6):362-8. PubMed ID: 8528681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between glomerular mesangial cells, cytokines, and extracellular matrix.
    Sterzel RB; Schulze-Lohoff E; Weber M; Goodman SL
    J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S126-31. PubMed ID: 1600127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanism in glomerular mesangial cell proliferation.
    Haas CS; Schöcklmann HO; Lang S; Kralewski M; Sterzel RB
    J Nephrol; 1999; 12(6):405-15. PubMed ID: 10626832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta (TGF-beta) stimulates the expression of beta1 integrins and adhesion by rat mesangial cells.
    Kagami S; Kuhara T; Yasutomo K; Okada K; Löster K; Reutter W; Kuroda Y
    Exp Cell Res; 1996 Nov; 229(1):1-6. PubMed ID: 8940242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta.
    López-Armada MJ; Gómez-Guerrero C; Egido J
    J Immunol; 1996 Sep; 157(5):2136-42. PubMed ID: 8757338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .
    Kitamura M; Sütö T; Yokoo T; Shimizu F; Fine LG
    J Immunol; 1996 Apr; 156(8):2964-71. PubMed ID: 8609417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases.
    Ortiz A; Gómez-Chiarri M; Alonso J; Bustos C; Gómez-Guerrero C; López-Armada MJ; Gómez-Garre D; Palacios I; Ruíz-Ortega M; Gutierrez S
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):55-74. PubMed ID: 8032716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glomerular extracellular matrix in glomerulosclerosis by molecular biology].
    Makino H
    Nihon Rinsho; 1992 Dec; 50(12):3038-45. PubMed ID: 1491457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple roles for platelet-derived growth factor in renal disease.
    Floege J; Johnson RJ
    Miner Electrolyte Metab; 1995; 21(4-5):271-82. PubMed ID: 7565476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of TGF-beta in glomerular diseases].
    Okuda S
    Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
    Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
    J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.
    Kuroiwa T; Lee EG; Danning CL; Illei GG; McInnes IB; Boumpas DT
    J Immunol; 1999 Aug; 163(4):2168-75. PubMed ID: 10438958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.